Tag: Julia C. Owens

Millendo Therapeutics begins human trial of VMS drug candidate MLE-301

pharmanewsdaily- September 24, 2020

Millendo Therapeutics has started a phase 1 clinical trial of its selective neurokinin 3 receptor (NK3R) antagonist MLE-301, which is being developed for the treatment ... Read More

Millendo Therapeutics wraps up merger with OvaScience

pharmanewsdaily- December 9, 2018

Millendo Therapeutics, a clinical-stage biopharma company engaged in developing drugs for orphan endocrine diseases, has wrapped up a previously announced merger with OvaScience, a Massachusetts-based ... Read More